IMVTImmunovant, Inc.

HealthcareUSD
$43.90

Is it growing?

Is IMVT growing?

Years of annual history on file
8

Years of annual history on file · FY2019 to FY2026, as filed

Details›
Revenue FY2022
$0
Revenue FY2023
$7.6M
Revenue FY2024
$25M

Annual income statements as filed with the SEC.

Biotechnology

Ranks #36 of 145 by Smart Score

Compare peers
PTGX+0.39%
Protagonist Therapeutics, Inc.
PCVX-0.35%
Vaxcyte, Inc.
SYRE+2.8%
Spyre Therapeutics, Inc.
IBRX-0.13%
ImmunityBio, Inc.
TGTX+0.06%
TG Therapeutics, Inc.
RYTM+0.66%
Rhythm Pharmaceuticals, Inc.